Speaker illustration

Associate Professor Tatjana Potpara

Belgrade University School of Medicine, Belgrade (Serbia)

Member of:

European Society of Cardiology

What is the best measure of outcomes for catheter ablation of atrial fibrillation (AF)?

Event: EHRA 2022

Topic: Rhythm Control, Catheter Ablation

Session type: Meet the Experts

Thumbnail

Optimising outcomes for atrial fibrillation patients undergoing cardiac interventions

Event: EHRA 2022

Topic: Oral Anticoagulation

Session type: Satellite Symposium

Thumbnail

Late Breaking Clinical Trials II - atrial fibrillation, news on ablation and sex differences

Event: EHRA 2022

Topic: Arrhythmias, General

Session type: Late-Breaking Science

Thumbnail

Controversy: can we propose atrial fibrillation ablation as first line therapy?

Event: ESC Asia with APSC & AFC 2021

Topic: Atrial Fibrillation (AF)

Session type: Debate Session

Thumbnail

Live Abstracts - Arrhythmias

Event: ESC Asia with APSC & AFC 2021

Topic: Arrhythmias, General

Session type: Abstract Sessions

Thumbnail

Optimal therapy of atrial fibrillation

Event: EHRA 2021

Topic: Treatment

Session type: Abstract Sessions

Thumbnail

The best of Europace Journal 2020

Event: EHRA 2021

Topic: Arrhythmias, General

Session type: Symposium

Thumbnail

2020 ESC Guidelines on Atrial Fibrillation - Live

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Atrial Fibrillation (AF)

Session type: New ESC Guidelines

Thumbnail

Atrial fibrillation - The "Big Picture"

Event: ESC CONGRESS 2019

Topic: Atrial Fibrillation (AF)

Session type: Special Session

Thumbnail

EHRA expert consensus papers - Key messages 1

Event: EHRA 2019

Topic: Clinical

Session type: New ESC Guidelines

Thumbnail

This platform is supported by

logo Novo Nordisk